Quotient Wealth Partners LLC Cuts Stock Holdings in CME Group Inc. (NASDAQ:CME)

Quotient Wealth Partners LLC trimmed its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 16.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,672 shares of the financial services provider’s stock after selling 329 shares during the quarter. Quotient Wealth Partners LLC’s holdings in CME Group were worth $369,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Groupama Asset Managment purchased a new stake in shares of CME Group in the 4th quarter valued at $25,282,000. Bluefin Capital Management LLC purchased a new position in CME Group during the 4th quarter worth $2,891,000. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main boosted its holdings in CME Group by 0.5% in the 4th quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 714,061 shares of the financial services provider’s stock valued at $150,381,000 after purchasing an additional 3,601 shares in the last quarter. FIL Ltd grew its holdings in CME Group by 0.7% during the fourth quarter. FIL Ltd now owns 4,269,327 shares of the financial services provider’s stock worth $899,120,000 after acquiring an additional 29,398 shares during the period. Finally, GLOBALT Investments LLC GA purchased a new position in shares of CME Group in the 4th quarter valued at about $1,222,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently issued reports on the company. JPMorgan Chase & Co. lifted their price target on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research note on Thursday, July 25th. TD Cowen started coverage on CME Group in a research note on Thursday, September 26th. They issued a “hold” rating and a $221.00 target price for the company. Royal Bank of Canada reissued a “sector perform” rating and set a $235.00 price objective on shares of CME Group in a research note on Thursday, October 3rd. Redburn Atlantic downgraded shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 target price for the company. in a research report on Tuesday. Finally, Bank of America raised their price objective on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research report on Thursday, October 3rd. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, CME Group has an average rating of “Hold” and a consensus price target of $217.71.

View Our Latest Analysis on CME

CME Group Trading Down 0.1 %

CME stock opened at $221.25 on Friday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The business’s 50 day moving average is $213.67 and its 200-day moving average is $207.83. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $226.78. The firm has a market cap of $79.66 billion, a P/E ratio of 25.17, a P/E/G ratio of 8.74 and a beta of 0.55.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.53 billion. During the same quarter in the previous year, the company posted $2.30 EPS. The business’s revenue for the quarter was up 12.7% compared to the same quarter last year. Equities analysts anticipate that CME Group Inc. will post 9.94 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were paid a $1.15 dividend. The ex-dividend date was Monday, September 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.08%. CME Group’s dividend payout ratio (DPR) is currently 52.33%.

Insider Buying and Selling

In related news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the firm’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at $2,877,504.39. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by insiders.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.